Stay updated on Nivolumab and SRS in Recurrent Meningioma Clinical Trial
Sign up to get notified when there's something new on the Nivolumab and SRS in Recurrent Meningioma Clinical Trial page.

Latest updates to the Nivolumab and SRS in Recurrent Meningioma Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedPlatform revision updated from v3.6.4 to v3.6.5, indicating a minor backend/UI release. No visible changes to the study page content are evident.SummaryDifference0.0%

- Check21 days agoChange DetectedUPMC Hillman Cancer Center was added as a participating site for the study. University of Pittsburgh Cancer Institute (UPCI) was removed.SummaryDifference0.2%

- Check29 days agoChange DetectedRevision label updated from v3.6.3 to v3.6.4. This update reflects a new page template/version used for the study page, without altering its content.SummaryDifference0.0%

- Check50 days agoChange DetectedThe page's revision tag was updated to v3.6.3, indicating a minor update to the page version without changing study information.SummaryDifference0.0%

- Check57 days agoChange DetectedThe page shows an updated revision tag from v3.6.0 to v3.6.2, indicating a small version update to the page. This update does not modify the study content or eligibility.SummaryDifference0.0%

- Check72 days agoChange DetectedRecruitment status updated to 'No longer looking for participants', indicating the study is not seeking enrollees. New help and navigation items were added (How to Read a Study Record, Common Questions, How to Join a Study), the Intervention/Treatment label was updated, and the page shows a revision label (Revision: v3.6.0).SummaryDifference0.3%

Stay in the know with updates to Nivolumab and SRS in Recurrent Meningioma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab and SRS in Recurrent Meningioma Clinical Trial page.